Cytokeratin 17 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cytokeratin 17 monoclonal antibodies for research applications. Cytokeratin 17 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytokeratin 17 is a type of intermediate filament protein that plays a crucial role in maintaining the structural integrity of epithelial cells. The protein is particularly important in wound healing and is often associated with various pathological conditions, including certain cancers and skin disorders. The expression of Cytokeratin 17 can serve as a biomarker for specific cellular processes, making it a significant focus in cancer research and diagnostics. Cytokeratin 17 monoclonal antibodies enable researchers to study protein expression patterns in different tissue types and cellular environments. Understanding Cytokeratin 17's distribution and regulation can provide valuable information about tissue development, disease progression, and potential therapeutic targets. Researchers can utilize Cytokeratin 17 monoclonal antibodies to explore protein interactions and signaling pathways in various biological systems. Santa Cruz Biotechnology monoclonal antibodies for Cytokeratin 17 support researchers worldwide in advancing our understanding of cellular processes and disease mechanisms.